circulating plasma cell levels as a prognostic biomarker in myeloma
Published 3 years ago • 56 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
4:22
prognostic value of mrd and circulating plasma cells in myeloma
-
3:03
the prognostic impact of circulating plasma cells in patients with multiple myeloma
-
2:00
the potential of studying circulating plasma cells in multiple myeloma
-
1:49
circulating tumor dna as a biomarker in multiple myeloma: pitfalls and future outlooks
-
5:59
what is hrmm (high-risk multiple myeloma)?
-
9:22
myeloma:interpreting test results | bmj learning
-
10:20
understanding multiple myeloma (multiple myeloma explained clearly)
-
2:49
circulating tumor cell burden as a component of staging in multiple myeloma
-
1:51
what influence do circulating myeloma plasma cells have on the treatment of multiple myeloma?
-
1:33
circulating tumor cells in multiple myeloma
-
3:05
identifying new therapeutic targets on the surfaceome of myeloma plasma cells with proteomics
-
1:53
the prognostic value of structural heterogeneity of chromosome 1q in multiple myeloma
-
3:00
current & emerging biomarkers in multiple myeloma
-
2:28
b-cells and pre-plasma cells are important reservoirs responsible for relapse in multiple myeloma
-
2:20
the role of myeloma b-cells & pre-plasma cell progenitors in disease relapse following therapy
-
1:23
non-invasive liquid biopsy to assess myeloma precursor disease pathology
-
2:46
managing patients with high-risk myeloma
-
2:44
myeloma qol through induction and maintenance
-
1:19
single-cell sequencing of circulating tumor cells to predict progression from mgus/smm
-
1:59
the growing importance of celmods in the treatment of r/r multiple myeloma
-
1:49
using flow cytometry to detect abnormal plasma cells in mgus & predict disease progression
-
50:47
monitoring circulating plasma cells in routine diagnostics in multiple myeloma